Analysts Set Crispr Therapeutics AG (NASDAQ:CRSP) Price Target at $72.86

Crispr Therapeutics AG (NASDAQ:CRSP) has been given a consensus rating of “Buy” by the eighteen ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, two have given a hold ...

from Google Alert - Business https://ift.tt/2ZYpqT6
Crispr Therapeutics AG (NASDAQ:CRSP) has been given a consensus rating of “Buy” by the eighteen ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, two have given a hold ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize